Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

Allie Goecke-Butler didn't choose to get diabetes at 24 and become insulin dependent, but yet she says, "staying alive is becoming more and more expensive." ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

The clinical practice guideline further provides information on how to transition patients and residents from sliding-scale ...

An estimated 5.6 million people in the UK are living with diabetes and rates are rising. Recent figures showed that 549,000 more people have been identified over the past year as being at risk of ...